As of January 30, 2025, we have enrolled 457 patients, of whom 176 (38%) are in the randomized cohort.

During peer review, it was noted that successful completion of this scientifically rigorous study is likely to have a positive impact in the field of urology, and to help surgeons and patients make patient-driven informed health care decisions.

Conflicts of interest: Khurshid R. Ghani is a consultant for Boston Scientific, Olympus Medical, Coloplast, and Karl Storz and has received grants from